Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peg-Neutropine vs Neulastim in breast cancer
NCT03404752Phase 3Unknown
- Sponsor
- Gema Biotech S.A.
- Start
- Aug 2015
- Primary completion
- Jun 2018
- Countries
- 1
01
Overview
A Phase 3 trial of pegfilgrastim in neutropenia, sponsored by Gema Biotech S.A.. Status: unknown.
02
Drugs
pegfilgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT03404752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03404752.